Synthesis, ADMET Properties, and In Vitro Antimicrobial and Antibiofilm Activity of 5-Nitro-2-thiophenecarbaldehyde N-((E)-(5-Nitrothienyl)methylidene)hydrazone (KTU-286) against <i>Staphylococcus aureus</i> with Defined Resistance Mechanisms
The emergence of drug-resistant <i>Staphylococcus aureus</i> is responsible for high morbidity and mortality worldwide. New therapeutic options are needed to fight the increasing antimicrobial resistance among <i>S. aureus</i> in the clinical setting. We, therefore, character...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The emergence of drug-resistant <i>Staphylococcus aureus</i> is responsible for high morbidity and mortality worldwide. New therapeutic options are needed to fight the increasing antimicrobial resistance among <i>S. aureus</i> in the clinical setting. We, therefore, characterized the in silico absorption, distribution, metabolism, elimination, and toxicity (ADMET) and in vitro antimicrobial activity of 5-nitro-2-thiophenecarbaldehyde N-((E)-(5-nitrothienyl)methylidene)hydrazone (KTU-286) against drug-resistant <i>S. aureus</i> strains with genetically defined resistance mechanisms. The antimicrobial activity of KTU-286 was determined by CLSI recommendations. The ADMET properties were estimated by using in silico modeling. The activity on biofilm integrity was examined by crystal violet assay. KTU-286 demonstrated low estimated toxicity and low skin permeability. The highest antimicrobial activity was observed among pan-susceptible (Pan-S) <i>S. aureus</i> (minimal inhibitory concentration (MIC) 0.5-2.0 µg/mL, IC<sub>50</sub> = 0.460 µg/mL), followed by vancomycin resistant <i>S. aureus</i> (VRSA) (MIC 4.0 µg/mL, IC<sub>50</sub> = 1.697 µg/mL) and methicillin-resistant <i>S. aureus</i> (MRSA) (MIC 1.0-16.0 µg/mL, IC<sub>50</sub> = 2.282 µg/mL). KTU-286 resulted in significant (<i>p</i> < 0.05) loss of <i>S. aureus</i> biofilm integrity in vitro. Further studies are needed for a better understanding of safety, synergistic relationship, and therapeutic potency of KTU-286. |
|---|---|
| Item Description: | 10.3390/antibiotics9090612 2079-6382 |